Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8877
|
pubmed:dateCreated |
1993-11-10
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
342
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
989
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8105234-Adult,
pubmed-meshheading:8105234-Antibodies, Anticardiolipin,
pubmed-meshheading:8105234-Female,
pubmed-meshheading:8105234-Humans,
pubmed-meshheading:8105234-Male,
pubmed-meshheading:8105234-Middle Aged,
pubmed-meshheading:8105234-Myocardial Ischemia,
pubmed-meshheading:8105234-Prognosis
|
pubmed:year |
1993
|
pubmed:articleTitle |
Anticardiolipin antibodies in ischaemic heart disease.
|
pubmed:publicationType |
Letter,
Comment
|